0001144204-17-012518.txt : 20170302 0001144204-17-012518.hdr.sgml : 20170302 20170302163031 ACCESSION NUMBER: 0001144204-17-012518 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170228 FILED AS OF DATE: 20170302 DATE AS OF CHANGE: 20170302 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: China Biologic Products, Inc. CENTRAL INDEX KEY: 0001369868 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 752308816 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 18TH FL, JIALONG INTERNATIONALBUILDING STREET 2: 19 CHAOYANG PARK ROAD, CHAOYANG DISTRICT CITY: BEIJING STATE: F4 ZIP: 100125 BUSINESS PHONE: 86-10-6598-3111 MAIL ADDRESS: STREET 1: 18TH FL, JIALONG INTERNATIONALBUILDING STREET 2: 19 CHAOYANG PARK ROAD, CHAOYANG DISTRICT CITY: BEIJING STATE: F4 ZIP: 100125 FORMER COMPANY: FORMER CONFORMED NAME: GRC Holdings, Inc. DATE OF NAME CHANGE: 20060721 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Gao David CENTRAL INDEX KEY: 0001331795 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34566 FILM NUMBER: 17659278 MAIL ADDRESS: STREET 1: C/ BEIJING MED-PHARM CORPORATION STREET 2: 600 W. GERMANTOWN PIKE, SUITE 400 CITY: PLYMOUTH MEETING STATE: PA ZIP: 19462 4 1 v460976_4.xml OWNERSHIP DOCUMENT X0306 4 2017-02-28 0 0001369868 China Biologic Products, Inc. CBPO 0001331795 Gao David 18TH FLOOR, JIALONG INTERNATIONAL BUILDING, 19 CHAOYANG PARK ROAD BEIJING F4 100125 CHINA 1 1 0 0 Chief Executive Officer Common Stock 2017-02-28 4 S 0 62604 100.69 D 449396 D Common Stock 2017-03-01 4 S 0 54049 100.57 D 395347 D Represents 62,604 shares of common stock sold in the open market at a weighted average price of $100.69 per share on Februray 28, 2017. The Reporting Person intends to use the proceeds from the sale to pay income tax due in connection with the scheduled vesting of certain restricted stock held by the Reporting Person and the exercise of certain stock options held by the Reporting Person. Represents 54,049 shares of common stock sold in the open market at a weighted average price of $100.57 per share on March 1, 2017. The Reporting Person intends to use the proceeds from the sale to pay income tax due in connection with the scheduled vesting of certain restricted stock held by the Reporting Person and the exercise of certain stock options held by the Reporting Person. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in the open market at prices ranging from $99.04 to $104.48, inclusive.* The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in the open market at prices ranging from $100.00 to $102.57, inclusive.* * The Reporting Person undertakes to provide to any security holders of the Issuer or the staff of the Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in Footnotes 2 and 3. /s/ David (Xiaoying) Gao 2017-03-02